SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-007565
Filing Date
2020-05-01
Accepted
2020-05-01 17:31:52
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 652495
2 ex31-1.htm EX-31.1 11669
3 ex31-2.htm EX-31.2 11535
4 ex32-1.htm EX-32.1 9317
  Complete submission text file 0001493152-20-007565.txt   2572996

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20200331.xml EX-101.INS 288499
6 XBRL SCHEMA FILE rttr-20200331.xsd EX-101.SCH 31349
7 XBRL CALCULATION FILE rttr-20200331_cal.xml EX-101.CAL 38848
8 XBRL DEFINITION FILE rttr-20200331_def.xml EX-101.DEF 114707
9 XBRL LABEL FILE rttr-20200331_lab.xml EX-101.LAB 243790
10 XBRL PRESENTATION FILE rttr-20200331_pre.xml EX-101.PRE 182401
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 20842021
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences